Alamar Biosciences, Inc.

NASDAQ: ALMR · Healthcare · Biotechnology

PublicHQ Fremont, CA · AlamedaCIK 0002104204Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 49

v0.1 · 5/100 weight · pillars only

↑ workforce scale, market scale · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

222

as of 2026-08-01

Market cap

$237.8M

as of 2026-08-01

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Alamar Biosciences, Inc.’s financial profile?

Alamar Biosciences, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Neumora Therapeutics, Inc. Common Stock——Anavex Life Sciences Corp.——Turn Therapeutics Inc.——Aurora Cannabis Inc.——Greenwich LifeSciences, Inc.——Immunic, Inc.——

Neighbors

Alameda →

Lam Research Corporation$18.4B85A Ross Stores, Inc.$22.8B79B+Block, Inc.$24.2B69B PG&E Corporation$24.9B70B Workday, Inc.$9.6B80B+Veeva Systems Inc.$3.2B81B+

Key facts

CEOYuling Luo

SectorHealthcare

IndustryBiotechnology

HeadquartersFremont, CA

ExchangeNASDAQ: ALMR

Employees222

IPO date2026-04-17

Latest filings

10-Q2026-08-11 8-K2026-08-10 8-K2026-07-15 10-Q2026-05-08 8-K2026-05-08 8-K2026-04-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.